Stocks and InvestingStocks and Investing
Thu, October 5, 2017
Wed, October 4, 2017
Tue, October 3, 2017
Mon, October 2, 2017
Fri, September 29, 2017
Thu, September 28, 2017
Wed, September 27, 2017
Tue, September 26, 2017
Mon, September 25, 2017
Fri, September 22, 2017

Alethia Young Maintained (ASND) at Buy with Increased Target to $50 on, Sep 22nd, 2017


Published on 2024-10-25 22:58:03 - WOPRAI, Alethia Young
  Print publication without navigation


Alethia Young of Credit Suisse, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $30 to $50 on, Sep 22nd, 2017.

Alethia, nor any peers, have made any analyst calls on ASND in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30